Flash Glucose Monitoring Market (By Application- Type 1-diabetes and Type 2- diabetes, Market By End Users- Hospital, Clinics, Academic & Research Institutes)- Global Industry Size, Share, Trends, and Forecast, 2018-2026

Category : Healthcare and Pharmaceuticals | Published at : November-2018 | Delivery Format : PDF | Status: Published | Pages : 0


Flash glucose monitoring is sensor technology which is majorly used in monitoring the glucose level trend of diabetes. This technology enables to test the blood sugar levels without pricking the finger. This technology is currently available in the Freestyle Libre system which has two parts­­- A small white disc and a reader. Rapidly development in the technology has improved the efficiency of the diagnosis and monitoring of the diseases. Flash glucose monitoring is a very efficient tool to in maintain blood glucose level on a daily basis.

 Market Dynamics

The major driving factor for the flash glucose monitoring market includes increasing diabetic population, rising aging population, increase in prevalence of various diseases such as hepatitis, and human immunodeficiency virus (HIV) infection, and advancement in the technology. According to the World Health Organization (WHO), in 2014, over 422 million people across glob were suffering from diabetes. Increasing demand for point of care testing is one of the factor supporting the growth of the market. According to the research it was observed that, obese and smoking people are more prone to the diabetes. Increasing number of obese population and changing lifestyle of the people has fueled the growth of the market. Additionally, technical advances in equipment are one of the major driver driving the market to grow.

However, lack of awareness and high cost of the devices coupled with reluctance to adopt recent technology are the restraining the growth of the market.

Market Classification and Overview

The global flash glucose monitoring market is segmented into application, and end user.

On the basis of application, the market is segmented into Type 1-diabetes and Type 2- diabetes.

On the basis of end users, the market is segmented into hospital, clinics, academic & research institutes and others.

Regional Overview

Geographically, the market is segmented into four major regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America dominates the global flash glucose monitoring market owing to the increasing prevalence of diabetes, presence of huge obese population, and changing lifestyle. According to the American Diabetic Association, in 2015, over 30.3 millions of Americas were suffering from diabetes. Additionally, well developed technology and high healthcare spending have led to increase the demand for flash glucose monitoring devices, which in turn driven the growth of the market. Europe holds the second leading position in the market owing to the huge government support, well developed technology and adoption of the advanced devices for the monitoring of the devices.

Asia Pacific is expected to be the fastest growing region. The growth of this region is majorly attributed to increasing number of the diabetic population, presence of rapidly developing economies and increasing per capita income of the people. However, LAMEA is holds the least market share but is expected to have a healthy growth in near future. The Middle East region holds the major share in the market owing to the high spending power of the people and presence of developed economies.

Report Coverage


Flash Glucose Monitoring Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year


Forecast Data

2018 – 2026

Market Stratification

 Application, End Users, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis


Market Participants

Some of the major players in the market are Abbott laboratories, Roche, Medtronic, Dexcom, Glysens, Senseonics, Animas, Ypsomed, and Omnipod

Market Segmentation

Market By Application

  • Type 1-diabetes
  • Type 2- diabetes

Market By End User

  • Hospital
  • Clinics
  • Academic & Research Institutes
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Cart Summary